¸ñÀû: Regeneration of the facial nerve using low level laser therapy (LLLT)
has been rarely reported. Polydeoxyribonucleotides (PDRN), a mixture
of short dexoribonucleotide polymers (non-toxic agonist and no
antigenic properties is a well-known stimulator of cell growth that
accelerates cell proliferation and can help with the wound healing. In
this study, we examined synergistic effect of topical sustained
release of PDRN/F-127 and LLLT on facial nerve regeneration in the
crush injury induced facial nerve paralysis of rat. ¹æ¹ý:The main trunk was crushed for one minute with a hemostat. Animal were
divided 5 groups; control group (n=4), group I (pluronic F-127 only,
n=4), group II (pluronic F-127/PDRN, n=4), group III (pluronic F-127 +
LLLT, n=4), and group IV (pluronic F-127/PDRN + LLLT, n=4). The
recovery of vibrissa fibrillation, action potential and facial nerve
blood flow (FNBF) were measured. °á°ú:Group IV demonstrated significantly better recovery compared to the
other groups. After the intervention, significant differences in
vibrissa fibrillation values were observed at all time points (p =
0.0028) according to the repeated one-way ANOVA. Group IV showed the
most notable recovery in facial muscle action potential and FNBF
compared to the other groups. °á·Ð:These findings suggest that PDRN and LLLT may work together
synergistically to enhance peripheral nerve regeneration. Future
research should investigate the underlying molecular mechanisms and
evaluate the potential clinical applications of this combined
treatment strategy. |